Paulis G, Romano G, Paulis A. Prevalence, psychological impact, and risk factors of erectile dysfunction in patients with Peyronie’s disease: a retrospective analysis of 309 cases. Res Rep. Urol. 2016;8:95–103.

PubMed  PubMed Central  Google Scholar 

Smith JF, Walsh TJ, Conti SL, Turek P, Lue T. Risk factors for emotional and relationship problems in Peyronie’s disease. J Sex Med. 2008;5:2179–84. https://doi.org/10.1111/j.1743-6109.2008.00949.x.

Article  PubMed  PubMed Central  Google Scholar 

Stuntz M, Perlaky A, des Vignes F, Kyriakides T, Glass D. The prevalence of Peyronie’s disease in the United States: a population-based study. PLoS One. 2016;11:e0150157. https://doi.org/10.1371/journal.pone.0150157.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Chung E, Gillman M, Rushton D, Love C, Katz D. Prevalence of penile curvature: a population-based cross-sectional study in metropolitan and rural cities in Australia. BJU Int. 2018;122:42–49. https://doi.org/10.1111/bju.14605.

Article  PubMed  Google Scholar 

Nguyen HM, Hellstrom WJ, Alzweri L, Chung A, Virasoro R, Tapscott A, et al. 108 Intralesional collagenase clostridium histolyticum causes meaningful improvement in men with peyronie’s Disease: the results of a multi-institutional analysis. J Sex Med. 2019;16:S55–6.

Article  Google Scholar 

Gelbard M, Goldstein I, Hellstrom WJ, McMahon CG, Smith T, Tursi J, et al. Clinical efficacy, safety and tolerability of collagenase clostridium histolyticum for the treatment of peyronie disease in 2 large double-blind, randomized, placebo controlled phase 3 studies. J Urol. 2013;190:199–207.

Article  CAS  PubMed  Google Scholar 

Gelbard MK, Lindner A, Kaufman JJ. The use of collagenase in the treatment of Peyronie’s disease. J Urol. 1985;134:280–3.

Article  CAS  PubMed  Google Scholar 

Nehra A, Alterowitz R, Culkin DJ, Faraday M, Hakim L, Heidelbaugh J, et al. Peyronie’s disease: AUA guideline. J Urol. 2015;194:745–53. https://doi.org/10.1016/j.juro.2015.05.098.

Article  PubMed  PubMed Central  Google Scholar 

Trost L, Huang H, Han X, Burudpakdee C, Hu Y. Treatment patterns and healthcare outcomes with collagenase clostridium histolyticum vs surgery in Peyronie’s disease: a retrospective claims database analysis. Sex Med. 2021;9:100321. https://doi.org/10.1016/j.esxm.2021.100321.

Article  PubMed  PubMed Central  Google Scholar 

Moghalu OI, Das R, Horns J, Campbell A, Hotaling JM, Pastuszak AW. Trends in treatment of Peyronie’s disease in adult men in the United States from 2008 to 2017—results from an encounter and claims database. Int J Impot Res. 2022;34:280–8. https://doi.org/10.1038/s41443-021-00430-x.

Article  CAS  PubMed  Google Scholar 

Oberlin DT, Liu JS, Hofer MD, Milose J, Matulewicz RS, Flury SC, et al. An analysis of case logs from American urologists in the treatment of Peyronie’s disease. Urology. 2016;87:205–9. https://doi.org/10.1016/j.urology.2015.08.033.

Article  PubMed  Google Scholar 

Masterson TA, Nackeeran S, Rainer Q, Hauser N, Marcovich R, Ramasamy R. Survey of microsurgery training availability in US urology residency programs. World J Mens Health. 2021;39:376–80. https://doi.org/10.5534/wjmh.190162.

Article  PubMed  Google Scholar